HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever Adds Alpha Brain Supplement Maker In Latest Wellness, Nutrition Portfolio Expansion

Executive Summary

Unilever North America announces plans to acquire Onnit Labs, maker of a line of brain health, fitness and wellness supplements. Onnit has a large following online, attracting 1m visitors to its digital platform per month. 

You may also be interested in...



Unilever To Fuel Skin Care, E-Commerce Engines With Paula’s Choice Acquisition

Paula’s Choice ticks skin-care and e-commerce boxes at a time of increased wellness and home shopping demand. The balance it strikes between acknowledging consumer ingredient preferences and upholding scientific method may also be part of the brand's appeal.

Unilever Gets Portfolio In Order While Riding Prestige Beauty, Functional Nutrition Growth

Unilever’s prestige beauty business, bulked up by acquisitions over the past five years, achieved 21% underlying sales growth in the FY 2021 first quarter. The firm has formed a new business unit, Elida Beauty, to house a number of smaller, non-core beauty and personal-care brands accounting for around 600m in revenues following talk of possible divestitures.

Nestlé Weighing Acquisition Of The Bountiful Company

Nestlé is in talks to acquire "all or part" of The Bountiful Company, owners of the Nature's Bounty brand and a leading player in the US supplements market. The Swiss firm revealed its interest in The Bountiful Company shortly after reporting double-digit growth at its Health Science business in Q1. 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151265

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel